Goserelin acetate |
Katalog-Nr.GC36180 |
Goserelinacetat (ICI-118630-Acetat), ein Decapeptid-Analogon des Gonadotropin-Releasing-Hormons (GnRH/LHRH), fungiert als GnRH-Agonist.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 145781-92-6
Sample solution is provided at 25 µL, 10mM.
Goserelin acetate (ICI 118630 acetate) is an injectable gonadotropin releasing hormone superagonist (GnRH agonist).IC50 value:Target: GnRH agonistGoserelin is used to treat hormone-sensitive cancers of the breast (in pre- and peri- menopausal women) and prostate, and some benign gynaecological disorders (endometriosis, uterine fibroids and endometrial thinning). In addition, goserelin is used in assisted reproduction and in the treatment of precocious puberty. It may also be used in the treatment of male-to-female transsexuals and is favoured above other anti-androgens in some countries, such as the UK. It is available as a 1-month depot and a long-acting 3-month depot. Goserelin stimulates the production of the sex hormones testosterone and estrogen in a non-pulsatile (non-physiological) manner.
Average Rating: 5
(Based on Reviews and 21 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *